Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Somatostatin for Sale > Somatostatin, Somatostatin Acetate, Somatostatin 14, Modustatina, SS-14, Stilamin, GH-RIF, SRIF-A, Aminopan, SRIF, Somatostatin Acetate API, Somatosta
Somatostatin, Somatostatin Acetate, Somatostatin 14, Modustatina, SS-14, Stilamin, GH-RIF, SRIF-A, Aminopan, SRIF, Somatostatin Acetate API, Somatosta buy - large image1
Somatostatin, Somatostatin Acetate, Somatostatin 14, Modustatina, SS-14, Stilamin, GH-RIF, SRIF-A, Aminopan, SRIF, Somatostatin Acetate API, Somatosta buy - image1
Somatostatin, Somatostatin Acetate, Somatostatin 14, Modustatina, SS-14, Stilamin, GH-RIF, SRIF-A, Aminopan, SRIF, Somatostatin Acetate API, Somatosta buy - image2
Somatostatin, Somatostatin Acetate, Somatostatin 14, Modustatina, SS-14, Stilamin, GH-RIF, SRIF-A, Aminopan, SRIF, Somatostatin Acetate API, Somatosta buy - image3

Somatostatin, Somatostatin Acetate, Somatostatin 14, Modustatina, SS-14, Stilamin, GH-RIF, SRIF-A, Aminopan, SRIF, Somatostatin Acetate API, Somatosta

GMP FDA COA

Unit Price: Get Latest Price
CAS No.:

51110-01-1

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Brand:

Chengdu Shengnuo, Shengnuo Biopharm

Packaging:

g

Price valid (until):

2025-11-16

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

  • Product Description

  • Seller Information

  • History Price

  • Description


      Product Detail  


    Somatostatin, Somatostatin Acetate, Somatostatin 14, Modustatina, SS-14, Stilamin, GH-RIF, SRIF-A, Aminopan, SRIF, Somatostatin Acetate API, Somatostatin Acetate Peptide, Peptide


    CAS No.: 51110-01-1

    Purity: ≥99% (HPLC)

    Appearance: White or off-white lyophilized powder

    Molecular Formula (14-peptide): C76H104N18O19S2

    Molecular Weight (14-peptide): 1637.88

    Storage   Conditions: -20°C±5°C (dry, protected from light)

    Sequence:

    Cyclo-(Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys)

    Amino Acid Count: Two forms—14-peptide (primary) and 28-peptide (more common in GI tract)

    Solubility: H2O: 1 mg/mL; Water solubility: 0.3 mg/mL

     

    Indications

    Natural somatostatin metabolizes too rapidly; synthetic analogs (e.g., octreotide, lanreotide) are clinically preferred. However, somatostatin is still used in acute settings in some countries. Indications:  

    Acute esophageal variceal bleeding

    Pancreatic fistulas post-surgery or due to pancreatitis

    Gastrointestinal fistulas post-surgery or due to pancreatitis

    Insulinoma or functional pancreatic tumors (symptomatic hypoglycemia relief)


    Certificates

    Basic Info
    Product Name:

    Somatostatin

    Other Name:

    Somatostatin;Growth hormone release-inhibiting factor;Somatotropin release-inhibiting factor;SRIF;AY 24910;Growth hormone release-inhibiting hormone;Somatostatin-14;Panhibin;Somatotropin release-inhibiting hormone;SIF;Aminopan;Somiaton;SRIF 14;GH-RIF;Somastin Sb;1: PN: WO2014070965 PAGE: 35 claimed sequence;52500-64-8;53126-12-8;56451-83-3

    CAS No.:

    51110-01-1

    InChIKeys:

    NHXLMOGPVYXJNR-UHFFFAOYSA-N

    Molecular Weight:

    1637.88

    Exact Mass:

    1636.716675

    EC Number:

    254-186-5

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    664

    XLogP3:

    -4.25

    Appearance:

    powder

    Density:

    1.4±0.1 g/cm3

    Boiling Point:

    1970.9±65.0 °C at 760 mmHg

    Flash Point:

    1145.7±34.3 °C

    Refractive Index:

    1.670

    Water Solubility:

    H2O: 1 mg/mL

    Storage Conditions:

    −20°C

    Toxicity:

    Intravenous-rat LD50: 21 mg/kg; Intravenous-mouse LD50: 33 mg/kg

    Flammability characteristics:

    Combustible; Fire site decomposes toxic nitrogen oxides, sulfur oxide fumes

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

    Location:

    Chengdu Shengnuo Biopharm Co., Ltd.

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    365

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2004

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.